Covid-19: FDA expert panel recommends authorising molnupiravir but also voices concerns
O Dyer - BMJ: British Medical Journal (Online), 2021 - search.proquest.com
An advisory panel of experts has voted by 13 to 10 to recommend that the US Food and
Drug Administration should grant an emergency authorisation to Merck's molnupiravir …
Drug Administration should grant an emergency authorisation to Merck's molnupiravir …
[PDF][PDF] Covid-19: FDA expert panel recommends authorising molnupiravir but also voices concerns
O Dyer - bmj, 2021 - scholar.archive.org
An advisory panel of experts has voted by 13 to 10 to recommend that the US Food and
Drug Administration should grant an emergency authorisation to Merck's molnupiravir …
Drug Administration should grant an emergency authorisation to Merck's molnupiravir …
Covid-19: FDA expert panel recommends authorising molnupiravir but also voices concerns
O Dyer - 2021 - bmj.com
An advisory panel of experts has voted by 13 to 10 to recommend that the US Food and
Drug Administration should grant an emergency authorisation to Merck's molnupiravir …
Drug Administration should grant an emergency authorisation to Merck's molnupiravir …
[引用][C] Covid-19: FDA expert panel recommends authorising molnupiravir but also voices concerns
O Dyer - BMJ (Clinical research ed.), 2021 - pubmed.ncbi.nlm.nih.gov
[引用][C] Covid-19: FDA expert panel recommends authorising molnupiravir but also voices concerns.
O Dyer - BMJ (Clinical Research ed.), 2021 - europepmc.org
Covid-19: FDA expert panel recommends authorising molnupiravir but also voices concerns. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …
Covid-19: FDA expert panel recommends authorising molnupiravir but also voices concerns
O Dyer - 2021 - bmj.com
An advisory panel of experts has voted by 13 to 10 to recommend that the US Food and
Drug Administration should grant an emergency authorisation to Merck's molnupiravir …
Drug Administration should grant an emergency authorisation to Merck's molnupiravir …